Mariana Brandao

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications

MR-ProADM Predicts Mortality and Heart Failure Events in ATTR Cardiac Amyloidosis.

MR-ProADM Predicts Mortality and Heart Failure Events in ATTR Cardiac Amyloidosis.

Journal: Circulation
Published: March 31, 2026

Upfront management of brain metastases in oncogene‑addicted NSCLC - An EORTC survey.

Upfront management of brain metastases in oncogene‑addicted NSCLC - An EORTC survey.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 14, 2026

Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.

Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 29, 2026

Improving Transthyretin cardiac amyloidosis detection from electrocardiograms through Willem AI platform.

Improving Transthyretin cardiac amyloidosis detection from electrocardiograms through Willem AI platform.

Journal: Heart rhythm
Published: January 27, 2026

Improving transthyretin cardiac amyloidosis detection from electrocardiograms through the Willem artificial intelligence platform.

Improving transthyretin cardiac amyloidosis detection from electrocardiograms through the Willem artificial intelligence platform.

Journal: Heart rhythm
Published: January 27, 2026

Targeting MET in EGFR-Mutated NSCLC.

Targeting MET in EGFR-Mutated NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 23, 2026

A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics, and pharmacodynamics of OSE-279, an anti-PD-1 monoclonal antibody in patients with advanced solid tumours.

A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics, and pharmacodynamics of OSE-279, an anti-PD-1 monoclonal antibody in patients with advanced solid tumours.

Journal: European journal of cancer (Oxford, England : 1990)
Published: January 02, 2026

Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry.

Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2025

Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysis.

Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysis.

Journal: Breast (Edinburgh, Scotland)
Published: November 11, 2025

Liver herniation into the pericardium.

Liver herniation into the pericardium.

Journal: European heart journal. Cardiovascular Imaging
Published: October 30, 2025

Locoregional therapies in advanced and recurrent pleural mesothelioma: A systematic review.

Locoregional therapies in advanced and recurrent pleural mesothelioma: A systematic review.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 09, 2025

Liver Herniation into the Pericardium.

Liver Herniation into the Pericardium.

Journal: European heart journal. Cardiovascular Imaging
Published: October 04, 2025
Showing 1-12 of 120

Last Updated: 09/26/2026